Target intelligence / Profile preview

Agouti-signaling protein (ASIP)

Target
ASIP
Molecular classification
Other (Secreted signaling protein; Inhibitor cystine knot fold)
01

Overview

Agouti-signaling protein (ASIP) is a small, secreted, paracrine signaling protein encoded by the ASIP gene in humans and other mammals. It acts as a competitive antagonist or inverse agonist at certain melanocortin receptors, primarily melanocortin 1 receptor (MC1R), where it blocks the action of α-melanocyte-stimulating hormone (α-MSH), switching melanin synthesis from eumelanin (dark pigment) to pheomelanin (red/yellow)[4]. The structure comprises a C-terminal cysteine-rich domain that adopts an inhibitor cystine knot fold, critical for high affinity binding and functional antagonism at MC1R[1][2][3]. In animal models, aberrant expression of ASIP is linked to yellow coat color and obesity, highlighting a role in energy homeostasis and metabolic regulation as well as pigmentation[1][4]. ASIP is not currently a common drug target nor routinely used as a therapeutic biomarker in clinical practice.

Other names
Agouti-signaling proteinASIPAGTIAGTILASPAgouti switch proteinnonagouti homolog (mouse)AGSWSHEP9nonagouti homologagouti switch protein
02

Mechanism of action

Competitive antagonist or inverse agonist at melanocortin receptors (especially MC1R) Inhibits α-melanocyte-stimulating hormone (α-MSH)-induced activity to shift melanin production from eumelanin (dark) to pheomelanin (red/yellow)[1][2][4]

03

Biological functions

Regulation of pigmentationParacrine signalingModulation of melanocortin receptor signalingAntagonist of melanocortin 1 receptor (MC1R)
04

Disease associations

Obesity (in animal models)Pigmentation disorders (e.g. albinism, coat color variation)Metabolic syndrome (in animal models)Other (potential modifier in diabetes, due to metabolic effects in mice)
05

Safety considerations

Modulation of ASIP expression in animals alters pigmentation and metabolic phenotypes (e.g., obesity in mice with ubiquitous ASIP expression); potential off-target effects or pleiotropic phenotypes if modulated therapeutically[1][2]

Beyond the preview

Go deeper on Agouti-signaling protein (ASIP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Agouti-signaling protein (ASIP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call